A Novel Method for Programmed Release of Biomolecules
Johns Hopkins University seeks a partner to commercialize a novel method for programmed release of biomolecules and nanoparticles. This is a useful tool for the controlled delivery of drugs, DNA, proteins, viruses, and nanoparticles. This invention provides a method to release small quantities of the molecule over time or a mixture of multiple molecules.
Click here to view high-quality marketing materials. Description (Set) • This device can be regenerated and reused multiple times, making it a cost-effective and efficient system.
• Its unique design creates a system in which multiple molecules can be loaded and released with spatial and temporal control.
• Small quantities of biomolecules or nanoparticles can be released (femtomolar or lower), allowing for a robust method of delivery for a variety of uses.
• This technology is not limited to a certain type of biomolecule or nanoparticle, thus positioning it as the next standard for controlled release.
• Furthermore, the low current requirements for powering the device make it biologically very safe for use in patients. This ensures wider utilization for different medical needs as well as a more energy efficient system.
• These devices are small, cheap, easily loaded, have no moving parts, and are biocompatible. Proposed Use (Set) • Controlled drug release devices
• Programmable DNA/protein arrays
• Gene expression platforms
• Lab-on-a-chip devices
• Protein purification systems
Patent (Set) 11/804,964
Type of Offer:
« More Medical Devices Patents